Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial - Wikidata - wikimedia - TriplyDB

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

http://www.wikidata.org/entity/Q24685678

about

Thalidomide for managing cancer cachexia Thalidomide for managing cancer cachexia Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)Pharmacology of manipulating lean body mass Nutritional status and nutritional support before and after pancreatectomy for pancreatic cancer and chronic pancreatitis Cachexia and pancreatic cancer: are there treatment options?Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma Dietary prevention of malignant glioma aggressiveness, implications in oxidant stress and apoptosis.Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways Fatigue in cancer: a review of literature Thalidomide and cancer cachexia: old problem, new hope?Novel treatments for cancer cachexia.Review article: palliative care in gynecologic oncology.Treatment of cachexia in oncology Optimal management of cancer anorexia-cachexia syndrome.Cancer cachexia: mechanisms and clinical implications.Non-steroidal anti-inflammatory drugs for the treatment of cancer cachexia: a systematic review.Pancreatic cancer cachexia: a review of mechanisms and therapeutics.Cancer cachexia, mechanism and treatment An Epidemiological Survey of Cachexia in Advanced Cancer Patients and Analysis on Its Diagnostic and Treatment Status.Change of body weight and macrophage inhibitory cytokine-1 during chemotherapy in advanced gastric cancer: what is their clinical significance?Cancer cachexia update in head and neck cancer: Pathophysiology and treatment.Thalidomide in dermatology: revisited.Target population for clinical trials on sarcopenia.Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia A Phase II dose titration study of thalidomide for cancer-associated anorexia.The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study.P-selectin genotype is associated with the development of cancer cachexia.3,6'-dithiothalidomide improves experimental stroke outcome by suppressing neuroinflammation.Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo Pentoxifylline treatment in patients with cancer cachexia: A double-blind, randomized, placebo-controlled clinical trial Pharmacological options for advanced cancer patients with loss of appetite and weight.Emerging drugs for the treatment of pancreatic cancer.Disrupting cytokine signaling in pancreatic cancer: a phase I/II study of etanercept in combination with gemcitabine in patients with advanced disease Cancer cachexia prevention via physical exercise: molecular mechanisms.Emerging drugs for cancer cachexia.Roles and potential therapeutic targets of the ubiquitin proteasome system in muscle wasting.Fatigue in palliative care patients -- an EAPC approach.NF-kappaB signaling in skeletal muscle: prospects for intervention in muscle diseases

P2860

Q24199109-798CF204-7CBC-4EEC-A61A-26BBFE764679 Q24235922-0D3DD24F-7179-45D4-9CC3-A909E3B0AE96 Q26747940-B30F4A38-B121-45ED-B78E-7886BE30A6E1 Q26824503-35D3720E-A9AE-4A00-9E61-91A040F98F87 Q26991979-97A20148-FAB7-41E9-9D47-F5B47DDEBE21 Q27026558-DC1AF7D8-4521-41CB-AA43-88EA340C3D24 Q28068034-CCB8C1E7-EE10-407A-949D-05F5C7573A51 Q28069864-17B2D74F-B553-4BFD-BB32-FFB68B34285A Q33328253-C8CA6C63-FC35-4D32-A170-D3DF6316AEEA Q33720208-02CDDA7B-CDF0-4B98-A4BF-8C072775D737 Q33915622-039F040B-5E72-439F-9396-676B4D346E18 Q33985598-2628751C-ADD8-4E84-9F8D-F8DB698EA28A Q34005616-ECD3C8F4-5922-4F68-AF43-01BF5A458861 Q34156710-2B5B96E5-02AB-4907-BBF2-7E07ECB1AA62 Q34158188-FF1876C7-B105-413D-ABE4-4F58A04461B7 Q34417908-01A7B3AD-06BD-4735-B43C-D928EDB9280F Q34631019-5B2CDF27-BC87-4E50-81A1-CBDA0B20DE6C Q34636946-E9025235-B5A7-4C5D-8A59-22B7B93D89B3 Q34660312-22F89AEA-3EC1-4084-9B17-9160A1AEB3B6 Q34669440-D7CC47F2-2D42-4B7C-8C5D-86330E095906 Q34672667-9D966736-C846-4A64-B9BB-680E15B5973E Q35106132-8A2D3FC3-9D41-4322-8B20-89CCDE48B069 Q35122201-105E085A-8D62-44F1-BB10-7DD9C83669CF Q35215252-7F374FD6-9181-4EDE-ACEA-51B522DA55BE Q35258802-CC54DB26-4FDD-4F3C-ADF8-AE76A2D6E06E Q35583902-FA335DD4-97D7-4BE7-AF4D-0A1DF8B8B721 Q35834646-F1F352A0-FCDA-420E-9ECB-DEAF29BFC708 Q36225307-F773259F-63EE-4F58-B516-E4B998162EB7 Q36238683-CDDFE10D-67E6-46E3-A02A-040CD5860DEA Q36727898-54B1EE48-4DA5-4E4A-99A8-1EBB17E01EA2 Q36756845-3FBAD7D5-9D4D-4A83-9545-2FE75A898E2C Q36801270-7776F935-F5D2-403E-B46A-B48F008A2C25 Q36828134-B5E10104-DED1-47EB-9A5C-70B0092DA15E Q36866617-51058D4F-2F85-402E-B94F-548CA08D7941 Q36876297-A653ED92-6366-49D1-99C8-94241AF94AEE Q36934986-878DBB1F-ABD7-4E10-8DFA-D8F77E509BCC Q36989913-04CF6CE5-4F96-4B0F-B664-3A002F251A34 Q37019253-372A3D03-6869-4EAD-A0B1-0D6B6BF25FDC Q37063833-40A6EF52-AB6A-481A-8D8C-4DC3A4B97950 Q37075935-A7E430F2-6098-4CE7-8636-67F820F0A28B

P2860

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

http://www.wikidata.org/entity/Q24685678

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

@ast

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

@en

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

@nl

type

label

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

@ast

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

@en

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

@nl

prefLabel

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

@ast

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

@en

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

@nl

P1433

Q24685678-B4522D02-51A5-4EE6-B388-7E726332465D

P1476

Q24685678-B73D5087-C141-4E01-A5E4-39E14A37F65F

P2093

Q24685678-0B07DFC5-4B09-428A-95B1-C5B4221A313B

Q24685678-49DE88D9-80F5-4036-A919-DA948E43D36C

Q24685678-6DF82D32-89F6-498C-B4E2-A7FEBAC67D1E

Q24685678-A432FFE8-A877-4D89-B5AE-F810C2350F01

Q24685678-BBB62965-0F8C-432F-9465-05DC95600C17

Q24685678-E22D6961-1909-496B-832E-9493A91D17BB

P2860

Q24685678-001E33E7-A0CF-4044-A64D-211F8289647E

Q24685678-015462A1-FA0B-49B9-BAD7-1BEDB5F97775

Q24685678-2237F614-DBA9-41BF-B3C8-3C73F03816C1

Q24685678-23172796-DAEE-4546-BEA8-BF71AFB2CF6C

Q24685678-29CFA2F8-CF02-48B7-8578-B58D0CE8ACF4

Q24685678-3818AE6C-DA2C-4DBB-9612-9B35ACF3E3F6

Q24685678-425785D5-BFD4-4884-83A8-DB2FEC7F7F5A

Q24685678-425EEE31-0D44-49F3-B18D-0ED047CF3316

Q24685678-43F5733B-04EB-442A-AE3F-1A10B3CF6EC6

Q24685678-44F011BE-462B-46AF-8737-F03DACEA0ED5

P304

Q24685678-04A288CB-8975-4D27-9D34-2B8B1927E1C8

P31

Q24685678-7E161CD6-9C0A-4DCC-9762-E9C113FFD7A3

P3181

Q24685678-C124A8E4-F1AE-4668-8573-4D5C6EB01018

P356

Q24685678-043F8F08-4DD4-4945-8795-8DD4A0E1C94A

P407

Q24685678-559E09A7-E072-48E4-A782-66AF067A0250

P433

Q24685678-D5CBB47A-815E-4FC4-B1FA-E1513E66EF23

P478

Q24685678-56016CB3-5247-4406-B0A9-2AF8627EB7B3

P577

Q24685678-5451D9CB-FCFF-4F7F-A5D9-CF72034176AF

P5875

Q24685678-F839B81C-6DFC-4CC5-A528-E155054BDC4C

P698

Q24685678-17102F92-EAD8-41B4-BDAA-63FC579D84A7

P921

Q24685678-2C679F8E-6EBC-4D2B-9511-E326D3B615D6

Q24685678-4D04A7FC-B09A-4456-8452-E552F0A4036D

P932

Q24685678-646CABD6-4EED-46FE-9344-783B58DB3E74

P3181

P356

GUT.2004.047563

P1433

P1476

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

@en

P2093

H D Duncan

http://www.w3.org/2001/XMLSchema#string

J N Gordon

http://www.w3.org/2001/XMLSchema#string

P M Goggin

http://www.w3.org/2001/XMLSchema#string

R D Ellis

http://www.w3.org/2001/XMLSchema#string

T Johns

http://www.w3.org/2001/XMLSchema#string

T M Trebble

http://www.w3.org/2001/XMLSchema#string

P2860

Anthropometric measurement of muscle mass: revised equations for calculating bone-free arm muscle area

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease

Cancer anorexia-cachexia syndrome: are neuropeptides the key?

The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer.

Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model.

Cancer anorexia and cachexia.

Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine.

Cachexia in cancer patients.

Oesophageal cancer and cachexia: the effect of short-term treatment with thalidomide on weight loss and lean body mass.

P304

540-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1158416

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/GUT.2004.047563

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7979861

http://www.w3.org/2001/XMLSchema#string

P698

15753541

http://www.w3.org/2001/XMLSchema#string

P921

P932

1774430

http://www.w3.org/2001/XMLSchema#string